NUCANA BIOMED LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 8247
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 891
 
 
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 466
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0312,302 PHOSPHORAMIDATE DERIVATIVES OF 5 - FLUORO - 2` - DEOXYURIDINE FOR USE IN THE TREATMENT OF CANCERApr 18, 17Nov 02, 17[A61K, C07H, C07F]
2017/0226,147 METHODS OF SEPARATING GEMCITABINE-PHOSPHATE DIASTEREOISOMERSSep 29, 15Aug 10, 17[C07H]
2017/0107,246 GEMCITABINE PRODRUGSJun 25, 15Apr 20, 17[C07H]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9655915 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancerNov 17, 15May 23, 17[A61K, C07H, C07F]
9321798 Phosphoramidite derivatives of gemcitabine for use in the treatment of cancerOct 05, 11Apr 26, 16[A61K, C07H, A01N]
9221866 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancerDec 04, 14Dec 29, 15[C07H, A61K, C07F]
8933053 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancerFeb 29, 12Jan 13, 15[A61K, C07H, C07F]
8263575 Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancerMar 16, 06Sep 11, 12[A61K, C07H]
7951787 Phosphoramidate compounds and methods of useJul 20, 04May 31, 11[A61K, C07H, A01N]

Expired/Abandoned/Withdrawn Patents

  • No Patents to Display

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.